NCT03230903

Brief Summary

The study aims to evaluate the efficacy of the MS HAT (Multiple Sclerosis Home Automated Telemanagement) System as an adjunct to the current standard of medical care for patients with MS (PwMS). The individual patient with MS will be the unit of analysis. For each participant, the investigators will assess the effect of Home Automated Telemanagement (HAT) on functional outcomes, levels of disablement including impairment, activity and participation, socio-behavioral parameters, and satisfaction with medical care as described below.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started Oct 2016

Longer than P75 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 4, 2017

Completed
7 months until next milestone

First Posted

Study publicly available on registry

July 27, 2017

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
Last Updated

February 18, 2021

Status Verified

February 1, 2021

Enrollment Period

3.9 years

First QC Date

January 4, 2017

Last Update Submit

February 16, 2021

Conditions

Keywords

Multiple SclerosisTelerehabilitationPhysical rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Cardiorespiratory fitness

    Cardiorespiratory fitness will be measured by oxygen consumption

    Baseline up to 6 months

Secondary Outcomes (5)

  • MS Self-efficacy scale

    Baseline up to 6 months

  • Exercise adherence

    Baseline up to 6 months

  • Center for Epidemiologic Studies Depression Scale (CES-D)

    Baseline up to 6 months

  • Berg Balance Scale (BBS)

    Baseline up to 6 months

  • 2-Minute Walk Test (2MWT)

    Baseline up to 6 months

Study Arms (2)

Home Telerehabilitation

EXPERIMENTAL

The physical telerehabilitation group will receive an exercise plan, exercise equipment, a computer, and access to a daily individualized exercise plan. Participants in this group will follow the exercise plan that is sent to their computer via the telerehabilitation software. Participants will have interactions with a physical therapist and an exercise physiologist throughout training intervention.

Other: Home telerehabilitation

Usual Care

SHAM COMPARATOR

The usual care group will receive an individualized exercise program at baseline however participants will not receive the home telerehabilitation system or exercise equipment. Participants assigned to the usual care group will also not have access to the study physical therapist or exercise physiologist during the intervention.

Other: Usual Care

Interventions

Patients will receive an individualized exercise plan sent to a computer at their home. Patients will have daily access to a physical therapist and exercise physiologist.

Home Telerehabilitation

Patients will receive a written individualized exercise plan during their baseline visit on top of their usual disease care.

Usual Care

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>21
  • Confirmed diagnosis of Multiple Sclerosis based on McDonald criteria
  • EDSS range 5.0-8.0
  • Mini-Mental State Examination (MMSE) \> 22 or presence of a caregiver to assist in daily exercise regimen

You may not qualify if:

  • Coronary artery disease
  • Congestive Heart Failure
  • Uncontrolled hypertension
  • Epilepsy
  • Pacemaker or implanted defibrillator
  • Unstable fractures or other musculoskeletal diagnoses

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia University Medical Center

New York, New York, 10032, United States

Location

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Joel Stein, MD

    Columbia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Simon Baruch Professor of Physical Medicine & Rehabilitation

Study Record Dates

First Submitted

January 4, 2017

First Posted

July 27, 2017

Study Start

October 1, 2016

Primary Completion

September 1, 2020

Study Completion

September 1, 2020

Last Updated

February 18, 2021

Record last verified: 2021-02

Locations